19
Feb 2026
Researchers developed DeepRare, an LLM-driven multi-agent diagnostic system that integrates clinical descriptions, phenotype data, and genomic information to improve rare disease identification. Across thousands of cases, the system showed higher diagnostic recall than existing AI tools and clinicians in benchmark testing, while providing traceable reasoning linked to medical evidence.
19
Feb 2026
A study of over 50,000 pregnant women in Norway during the 2023/24 influenza season found that only 29.9% were vaccinated against influenza and 12.1% against COVID-19 during pregnancy, remaining far below recommended targets.
19
Feb 2026
When you finish a run, your muscles may feel like they did all the work. But researchers at The Jackson Laboratory (JAX) and the University of Pennsylvania (UPenn) have discovered that what happens in your brain after a run may determine whether you gain endurance over time.
19
Feb 2026
With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients undergoing transcatheter aortic valve implantation in a study presented today at the EAPCI Summit 2026.
19
Feb 2026
Food insecurity can increase anxiety and undermine employees at work, but workplace programs to address it can improve job outcomes, according to research published by the American Psychological Association.
19
Feb 2026
Exposure to infection and other immune stress in the womb increases the likelihood of alcohol misuse in adulthood, a risk that may be reduced through prenatal antioxidant treatment, a new Washington State University study shows.
19
Feb 2026
Doctors usually focus on a person's average blood pressure, but research increasingly shows that how much blood pressure fluctuates from moment to moment is just as important.
19
Feb 2026
The urgent onset of "the munchies" after cannabis use isn't imaginary – it's a cognitive response that occurs regardless of sex, age, weight or recent food consumption and could offer clues to help people struggling with appetite loss.
19
Feb 2026
New medical developments make it possible to treat an increasing number of severe and rare diseases with novel, high-cost pharmaceuticals.
19
Feb 2026
A new study led by Marie-Pierre Sylvestre, professor at the Université de Montréal School of Public Health, examines cannabis use 4 to 5 years after Canadian legalization by adopting a different perspective: rather than focusing solely on at-risk cases or those associated with problems, it identifies the socio-demographic, mental health, and lifestyle profiles of those who present a low risk of cannabis use disorder (CUD).
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
